Category list : Anti-asthmatic agents
Sort by: Newest first Oldest first A-Z Z-A
-
Personalised medicine approach could benefit people with asthma Subscription
Prescribing asthma treatment based on genetic differences could improve outcomes, results presented at the European Respiratory Society International Congress have suggested.
-
Novel once-daily fixed-dose ICS–LABA improves lung function over ICS monotherapy, research finds Subscription
A once-daily fixed-dose combination of inhaled corticosteroids and long-acting β2-adrenoceptor agonist significantly improved lung function over inhaled corticosteroids alone, a phase III study has concluded.
-
Once-daily ICS-LABA-LAMA superior to ICS-LABA in improving lung function, research suggests Subscription
A study in The Lancet Respiratory Medicine indicates that ICS-LABA-LAMA once daily is better than ICS-LABA in improving lung function.
-
Reducing asthma medication does not worsen outcomes but could save money, study suggests Subscription
Stepping down asthma medication does not adversely affect patient outcomes and could save millions of pounds in medicines costs, a study in PLoS Medicine has found.
-
Asthma inhaler stocks low after COVID-19 linked demand spike, government says
Pharmacies are experiencing difficulties sourcing some commonly used asthma inhalers, following a surge in demand caused by the COVID-19 pandemic, The Pharmaceutical Journal can reveal.
-
Why we must urgently rethink prescribing short-acting bronchodilators for asthma Subscription
Guidelines from the Global Initiative for Asthma present a radical overhaul of the way we manage asthma; but our current approach isn’t working, and nothing will change if it is not challenged.
-
Asthma exacerbations during pregnancy linked to birth complications Subscription
Women with asthma who experience exacerbations during pregnancy are more likely to have birth complications than women with well-controlled asthma, a study published in the European Respiratory Journal has suggested.
-
Triple-therapy inhaler improves lung function in adults with asthma Subscription
Combining three therapies into one inhaler improves lung function and reduces exacerbations in adults with uncontrolled asthma, researchers have concluded in a paper published in The Lancet.
-
Inhaled steroids no more effective than placebo for some mild asthma patients, study finds Subscription
The majority of patients with mild, persistent asthma who had a low level of eosinophils, showed no significant difference in their response to an inhaled corticosteroid when compared to placebo, study results have shown.
-
Third biological treatment for severe asthma approved by NICE
An injectable drug for patients who struggle to control their asthma with inhalers has been approved by the National Institute for Health and Care Excellence.
-
Dupilumab helps severe asthma patients cut glucocorticoid use Subscription
Research has shown dupilumab reduces glucocorticoid use by more than 70% and the number of severe asthma exacerbations by almost 60%.
-
Combined-drug inhaler provides better mild asthma symptom control than SABA alone, researchers find Subscription
Use of an inhaled glucocorticoid plus a fast-acting beta-2-agonist provided superior asthma symptom control in patients with mild asthma, compared with use of a short-acting beta agonist alone, researchers have found.
-
Increasing inhaled steroid dosage does not reduce severe exacerbations in children with mild-moderate asthma Subscription
Increasing the inhaled glucocorticoid dosage in children with mild-moderate asthma at times of poor asthma control does not reduce the rate of severe asthma exacerbations, a study has shown.
-
Quadrupling steroid inhaler dose cuts serious asthma attacks Subscription
A study has shown that temporarily quadrupling the dosage of inhaled corticosteroids during periods of worsening asthma cuts the rate of serious asthma attacks by 20%.
-
Asthmatic women using only short-acting treatments take longer to conceive, study finds Subscription
Asthmatic women who only use short-acting treatment are more likely to have difficulty conceiving compared with women who rely on longer-acting medication to manage their condition.
-
Pharmacist review of asthma patients is cost-effective, Italian study finds
A study conducted in Italy has found that a medicines use review (MUR) for asthma, with a protocol adapted from the UK, had a beneficial effect on patients’ asthma control and was cost effective compared with usual care.
-
Advice to give to asthma patients about air pollution Subscription
Two-thirds of people with asthma in the UK say poor air quality makes their asthma worse, which puts them at higher risk of an asthma attack.
-
Study identifies most important inhaler technique errors that are linked to poor asthma outcomes
A study of 3,660 patients across eight countries has identified the types of inhaler technique errors that are associated with the greatest impact on asthma outcomes.
-
A quick intervention recommendation by community pharmacists for patients using inhalers Subscription
Many pharmacists are probably busy reviewing inhaler use and technique as part of their medicines use reviews and new medicine service processes for patients with asthma and chronic obstructive pulmonary disease (COPD).
-
Patients need training to use inhalers properly, study finds
Ellipta inhaler device comes out on top in GSK-sponsored research comparing several types of inhaler devices and their misuse among COPD and asthma patients.
Show 10 per page20 per page50 per page
